Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function

Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function

BackgroundSubclinical thyrotoxicosis (SCT) is defined by low or undetectable thyroid-stimulating hormones and normal thyroid hormones. The treatment of SCT is uncertain despite being associated with increased cardiovascular risk (CVR) and mortality. Circulating endothelial progenitor cells (cEPCs) a...

Full description

Bibliographic Details
Main Authors:	Jason Phowira, Sherin Bakhashab, Anuradha Doddaballapur, Jolanta U. Weaver
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Endocrinology
Subjects:	subclinical thyrotoxicosis endothelial progenitor cells cardiovascular risk circulating angiogenic cells proangiogenic cells apoptosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.894093/full

Similar Items

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up
by: Jason Phowira, et al.
Published: (2022-03-01)

Decoding of miR-7-5p in Colony Forming Unit–Hill Colonies as a Biomarker of Subclinical Cardiovascular Disease—A MERIT Study
by: Sherin Bakhashab, et al.
Published: (2023-07-01)

Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study
by: Jason Phowira, et al.
Published: (2022-08-01)

Deciphering the Role of miR-200c-3p in Type 1 Diabetes (Subclinical Cardiovascular Disease) and Its Correlation with Inflammation and Vascular Health
by: Sherin Bakhashab, et al.
Published: (2022-12-01)

A pharmacotherapy of atrial fibrillation in subclinical thyrotoxicosis
by: R.F. Rakhmatullov, et al.
Published: (2021-09-01)

Detection of Angiogenic T Cells and Endothelial Progenitor Cells in Behçet Disease and Determination of Their Relationship with Disease Activity
by: Ayhan Kul, et al.
Published: (2023-05-01)

Control of the immune response by proangiogenic factors
by: Thibault eVORON, et al.
Published: (2014-04-01)

Endothelial progenitor cell biology in disease and tissue regeneration
by: Shanmugam Arulkumaran, et al.
Published: (2011-05-01)

Endothelial Progenitor Cells and Rheumatoid Arthritis: Response to Endothelial Dysfunction and Clinical Evidences
by: Klara Komici, et al.
Published: (2021-12-01)

<i>HTRA1</i> Regulates Subclinical Inflammation and Activates Proangiogenic Response in the Retina and Choroid
by: Waseem Ahamed, et al.
Published: (2022-09-01)

Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells
by: Ghazaleh Hashemi, et al.
Published: (2022-08-01)

Impairment of muscular endothelial cell regeneration in dermatomyositis
by: D. Lemmer, et al.
Published: (2022-10-01)

Origins and functional differences of blood endothelial cells
by: Ng, Chun Yi, et al.
Published: (2023)

Angiogenesis by BMP-2-PDLLA-Biohybrids in Co-Culture with Osteoblasts and Endothelia
by: Dohle Eva, et al.
Published: (2021-10-01)

Interrelation of galectin-3 and circulating proangiogenic endothelial cells in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014-08-01)

MicroRNA Expression Profiling of Bone Marrow–Derived Proangiogenic Cells (PACs) in a Mouse Model of Hindlimb Ischemia: Modulation by Classical Cardiovascular Risk Factors
by: Michel Desjarlais, et al.
Published: (2020-08-01)

Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
by: U. A. Tsoy, et al.
Published: (2021-08-01)

ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction
by: Fei Luo, et al.
Published: (2018-08-01)

Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer
by: P.K.Y. Goon, et al.
Published: (2006-02-01)

Acute myopathy secondary to amiodarone-induced thyrotoxicosis
by: Dave Duggan, et al.
Published: (2021-12-01)

The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo
by: Lucía Beltrán-Camacho, et al.
Published: (2022-04-01)

Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy
by: Sherin Bakhashab, et al.
Published: (2024-01-01)

Graphene Oxide Scaffold Stimulates Differentiation and Proangiogenic Activities of Myogenic Progenitor Cells
by: Mateusz Wierzbicki, et al.
Published: (2020-06-01)

Refractory Thyrotoxicosis in Oropharyngeal Squamous Cell Carcinoma Invading the Thyroid Gland
by: Lih Khuang Go, MBBS, et al.
Published: (2022-01-01)

Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
by: Siqi He, et al.
Published: (2022-04-01)

The relationship between serum uric acid level and concentration of proangiogenic endothelial progenitor cells in chronic heart failure patients
by: A. A. Kremzer
Published: (2017-08-01)

MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)
by: David J. Coulson, et al.
Published: (2021-04-01)

Electromyographic Changes in Thyrotoxicosis
by: Khalid I. Mussa
Published: (2007-04-01)

Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases
by: Dorota M. Radomska-Leśniewska, et al.
Published: (2021-06-01)

Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases
by: Lina Zhao, et al.
Published: (2017-06-01)

"Prevalence of Thyrotoxicosis: Clinical presentation and results of treatment in 384 patients with Goiter under 18 years "
by: "Moayeri H, et al.
Published: (2002-08-01)

"Prevalence of Thyrotoxicosis: Clinical presentation and results of treatment in 384 patients with Goiter under 18 years "
by: "Moayeri H, et al.
Published: (2002-12-01)

ALTERED EXPRESSION OF SURFACE RECEPTORS AT EA.HY926 ENDOTHELIAL CELL LINE INDUCED WITH PLACENTAL SECRETORY FACTORS
by: O. I. Stepanova, et al.
Published: (2014-07-01)

Unmarked Case of Amiodarone-Induced Thyrotoxicosis
by: N. I. Volkova, et al.
Published: (2011-09-01)

Fat extract improves fat graft survival via proangiogenic, anti-apoptotic and pro-proliferative activities
by: Hongjie Zheng, et al.
Published: (2019-06-01)

Characterization of Endothelial Progenitor Cell: Past, Present, and Future
by: Amankeldi A. Salybekov, et al.
Published: (2022-07-01)

Research progress on differential diagnosis of thyrotoxicosis during pregnancy
by: Guo Nian, Xue Meng, Liang Zhen
Published: (2022-11-01)

Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
by: Kuo Yu-Hsuan, et al.
Published: (2012-12-01)

No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction
by: Alejandro Diego‐Nieto, et al.
Published: (2018-10-01)

Gender and endothelial progenitor cell number in middle-aged adults
by: Brian L. Stauffer, et al.
Published: (2008-11-01)